Psychiatrist exposed in Grassley investigation resigns after failing to report hundreds of thousands in Pharma funds

Charles Nemeroff, who failed to disclose to Emory University approximately $800,000 in payments he received from drug maker GlaxoSmithKline (GSK) while he was the principal investigator (PI) on a multi-million dollar grant from the NIH to study five GSK antidepressants, is leaving the university.

Bob Grant
TheScientist.com
November 2, 2009

The Emory University psychiatry researcher who failed to report hundreds of thousands of dollars in pharmaceutical company payouts while receiving millions of dollars in funding from the National Institutes of Health to study the company’s anti-depressant drugs is leaving the university, according to the Atlanta Journal Constitution.

Charles Nemeroff,  a renowned depression researcher, failed to disclose to Emory approximately $800,000 in payments he received from drug maker GlaxoSmithKline (GSK) while he was the principal investigator (PI) on a multi-million dollar grant from the NIH to study five GSK antidepressants. Amid an investigation conducted by Emory, Nemeroff stepped down from his position as chairman of the psychiatry department last October. Later that month, the psychiatrist stepped down as PI from the $9.3 million NIH grant as the Senate probed his failure to disclose income from GSK, and the NIH froze funding on the five-year grant.

Read entire article: http://www.the-scientist.com/blog/display/56127/

SHARE YOUR STORY/COMMENT